EHA 2025: Nordic AML Group Explores Optimized Regimen for AML Patients
/ Anne Louise Tølbøll Sørensen
Nordic AML Insights: Research and Ph.D. Contributions
/ Jan Andreasen
AML Insights: What’s New in the Field
/ Jan Andreasen
Liposomal Daunorubicin + Cytarabine: Enhanced Synergistic Antineoplastic Effect in AML Treatment
/ Andrea Lenartova / Jan Andreasen
Functional Characterization for Germline Variants in Patients with MDS and AML
/ Nikolaj Juul Nitschke